INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Navigating The New USP Chapter <382> For Elastomeric Closures
Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.
-
Practical USP <1665>/<665> Guide To E&L Risk Assessment
A practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.
-
A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies
EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.
-
How To Choose The Right Bowie-Dick Test Pack For Your Steam Sterilizer
Bowie-Dick testing is essential for compliance, but the choice between disposable and reusable systems impacts cost, waste, and efficiency. Learn how to balance sustainability with sterility assurance.
-
Step Into The Future Of ATMP Fill-Finish5/21/2025
Discover the future of ATMP manufacturing as Josh Russell from AST demonstrates an advanced, fully automated fill-finish system featuring automated bag and tub opening, as well as the Atmos isolator.
-
Bulk Filling Of Drug Substance | Accurate Aliquoting4/24/2024
Bulk filling drug substances in traditional facilities is often a lengthy, manual process where operators are relied upon to adjust pump controls to achieve accurate filling. This method, spanning multiple shifts, increases process risk through errors that can compromise accuracy.
-
Stability Issues Unique To Liquid Injectables And How To Avoid Them3/23/2026
Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.
-
Agile Sterile Injectable Filling for Faster Market Entry9/21/2025
CMOs specializing in sterile injectable filling help pharmaceutical companies speed up product development and commercialization through flexible manufacturing, adaptability, and strong collaboration.
-
How DFM Promotes Scalability, Repeatability, And Profitability6/28/2024
Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
AST’s ASEPTiCell® and GENiSYS® systems combine industry-proven technologies such as robotics and isolator-barrier systems to provide flexible pharmaceutical aseptic filling and closing of ready-to-use vials, syringes, and cartridges with a single machine. These innovative platforms use a modular design approach to provide a truly adaptive system with the capabilities and features necessary for cGMP production of clinical and commercial sterile injectable products.
-
Examine a customizable imaging workstation designed for complex research needs, combining precision engineering, flexible components, and intuitive software to support advanced applications.
-
Reusable Process Challenge Device (PCD) designed for routine monitoring of pre-vacuum steam sterilizers.
-
A global partner offering prefillable drug‑delivery systems, manufacturing expertise, and integrated services that accelerate development, secure supply, and support therapies across multiple areas.
-
Modernize oligonucleotide manufacturing with robust filtration systems built for hazardous environments. Enhance purity and speed across every batch to ensure reliable and scalable production.